Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1.
Park S, Bang SY, Kwag D, Lee JH, Kim TY, Lee J, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ.
Park S, et al. Among authors: bang sy.
Bone Marrow Transplant. 2024 Jun;59(6):813-823. doi: 10.1038/s41409-024-02255-w. Epub 2024 Mar 4.
Bone Marrow Transplant. 2024.
PMID: 38438648